Regeneron Archives - Zxcoachoutlet

Regeneron board member and executive sell $1 million in stock after Trump touts treatment

October 10, 2020

A Regeneron executive and one of its directors sold $1 million worth of stocks two days after President Donald Trump announced he was taking their therapeutic, recent filings from the Securities and Exchange Commission reveal.

a sign on the side of a building: Regeneron Begins Human Trials Of Coronavirus Antibody Cocktail

© Michael Nagle
Regeneron Begins Human Trials Of Coronavirus Antibody Cocktail

Last Friday night, the White House announced that as part of Trump’s treatment for coronavirus, he had received Regeneron’s experimental antibody cocktail that has not passed formal trials or been approved by the Food and Drug Administration.

One day later, the president appeared in a video posted to his Twitter account about his treatment at Walter Reed National Military Medical Center.

“They gave me Regeneron,” he said, saying the company name instead of the treatment’s name, REGN-COV2. “It was like, unbelievable. I felt good immediately. I felt as good three days ago as I do now.”

At another point in the video he

Overnight Health Care: Regeneron asks for emergency authorization of coronavirus treatment Trump received | McConnell says he hasn’t visited White House in two months due to coronavirus

October 8, 2020

| No Comments

| insurance

Welcome to Thursday’s Overnight Health Care.

Donald Trump wearing a suit and tie: Overnight Health Care: Regeneron asks for emergency authorization of coronavirus treatment Trump received | McConnell says he hasn't visited White House in two months due to coronavirus | Employer-sponsored health insurance premiums rise 4 percent

© Getty Images
Overnight Health Care: Regeneron asks for emergency authorization of coronavirus treatment Trump received | McConnell says he hasn’t visited White House in two months due to coronavirus | Employer-sponsored health insurance premiums rise 4 percent

Regeneron filed for emergency authorization of its antibody COVID-19 treatment drug, just hours after President Trump claimed it basically cured him. Mitch McConnell hasn’t been to the White House in months, and a new analysis shows Americans’ job-based health care is continually getting more expensive.

Load Error

We’ll start with Regeneron:

Regeneron asks for emergency authorization of coronavirus treatment Trump received

Biotech company Regeneron late Wednesday applied for emergency authorization for an experimental antibody treatment praised by President Trump.

“Subsequent to our discussions with regulatory authorities, we have submitted a request to the U.S. Food and Drug Administration for an Emergency Use Authorization (EUA) for

Is Regeneron a Buy After Trump Touts Covid-19 Treatment?

October 8, 2020

| No Comments

| business

Shares of Regeneron (REGN) – Get Report continue to bubble higher for the bulls. The stock was rising 2% on Thursday, but for the week it’s up 7.5%.

The boost is coming after President Trump took Regeneron’s Covid-19 cocktail in an effort to combat the coronavirus. His quick return to the White House and positive commentary on Regeneron isn’t hurting either.

Now the company is going for emergency approval from the Food and Drug Administration.

The stock has been on fire in 2020, although not so much over the last few months. When the rest of the market started to tank in late February, Regeneron shares began to rally.

Shares are still up about 60% on the year, despite pulling back 18.75% from peak to trough earlier this summer.

Can the stock get back its mojo and continue higher from here? Let’s look at the charts.

Trading Regeneron

Regeneron, JPMorgan, Domino’s Pizza: 5 Things You Must Know

October 8, 2020

| No Comments

| business

Here are five things you must know for Thursday, Oct. 8:

1. — Stock Futures Rise on Stimulus Optimism

Stock futures traded higher Thursday as Wall Street grew more optimistic lawmakers could secure further fiscal stimulus for the U.S. economy even if it comes in the form of smaller relief bills.

Contracts linked to the Dow Jones Industrial Average were up 105 points, S&P 500 futures gained 14 points and Nasdaq futures rose 85 points.

Stocks finished sharply higher Wednesday after President Donald Trump said he would consider alternative aid measures such as a new round of stimulus checks, the Paycheck Protection Program and support for airlines. House Speaker Nancy Pelosi also signaled support for a standalone airline stimulus bill.

Airlines have begun furloughing or laying off workers following the expiration of a federal prohibition on job cuts tied to the $25 billion in federal aid they received earlier this

Gilead, Regeneron, Amgen: Covid Treatment Stocks Still Worth Looking At As Vaccine Nears?

October 5, 2020

| No Comments

| business

Our indicative theme on Covid-19 Treatment Stocks â which includes companies selling or developing treatments for Covid-19 âÂ is up by 13% year-to-date, compared to the S&P 500 which is up about 4%. While anti-viral therapeutics are quite complex to develop, companies have largely been adapting existing therapies for Covid treatments while also developing new treatment options. Now the long-term demand for Covid-19 treatments is hazy, considering that the development of a safe and effective vaccine could drastically reduce or possibly eliminate the need for treatments. However, most of the companies on the list have other established products that provide significant downside protection. Below is a bit more about these companies and how they have fared this year.

Regeneron Pharmaceuticals (REGN) recently indicated that its experimental Covid-19 treatment that involves a cocktail of two antibodies was effective in reducing viral loads and improving symptoms in non-hospitalized Covid-19 patients. The stock

M	T	W	T	F	S	S
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30
31